PI3K/PTEN/Akt and TSC/mTOR signaling pathways, ovarian dysfunction, and infertility: an update

被引:188
|
作者
Makker, Annu [1 ]
Goel, Madhu Mati [1 ]
Mahdi, Abbas Ali [2 ]
机构
[1] King Georges Med Univ, Postgrad Dept Pathol, Lucknow 226003, Uttar Pradesh, India
[2] King Georges Med Univ, Dept Biochem, Lucknow 226003, Uttar Pradesh, India
关键词
PI3K/PTEN/Akt and TSC/mTOR pathways; ovarian function; oogenesis; folliculogenesis; infertility; FOLLICLE-STIMULATING-HORMONE; PROTEIN-KINASE-B; OOCYTE-SPECIFIC DELETION; PRIMORDIAL GERM-CELLS; GRANULOSA-CELLS; GROWTH-FACTOR; IN-VITRO; MEIOTIC MATURATION; MOUSE OOCYTES; KIT-LIGAND;
D O I
10.1530/JME-14-0220
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Abnormalities in ovarian function, including defective oogenesis and folliculogenesis, represent a key female reproductive deficiency. Accumulating evidence in the literature has shown that the PI3K/PTEN/Akt and TSC/mTOR signaling pathways are critical regulators of ovarian function including quiescence, activation, and survival of primordial follicles, granulosa cell proliferation and differentiation, and meiotic maturation of oocytes. Dysregulation of these signaling pathways may contribute to infertility caused by impaired follicular development, intrafollicular oocyte development, and ovulation. This article reviews the current state of knowledge of the functional role of the PI3K/PTEN/Akt and TSC/mTOR pathways during mammalian oogenesis and folliculogenesis and their association with female infertility.
引用
收藏
页码:R103 / R118
页数:16
相关论文
共 50 条
  • [1] TARGETING THE PI3K/AKT/MTOR SIGNALING PATHWAYS IN CYSTIC FIBROSIS
    Reilly, R.
    Mroz, M.
    Dempsey, E.
    Shields, S.
    Wynne, K.
    McKone, E. F.
    Hiebel, C.
    Behl, C.
    Coppinger, J.
    PEDIATRIC PULMONOLOGY, 2016, 51 : 200 - 200
  • [2] The PI3K/Akt/mTOR signaling pathway
    Dennis, P. A.
    ANNALS OF ONCOLOGY, 2011, 22 : 19 - 19
  • [3] Pharmacological modulation of PI3K/PTEN/Akt/mTOR/ERK signaling pathways in ischemic injury: a mechanistic perspective
    Khan, Heena
    Singh, Aditi
    Singh, Yashvardhan
    Sharma, Diksha
    Dua, Kamal
    Grewal, Amarjot Kaur
    Singh, Thakur Gurjeet
    METABOLIC BRAIN DISEASE, 2025, 40 (03)
  • [4] Mosaic Disorders of the PI3K/PTEN/AKT/TSC/mTORC1 Signaling Pathway
    Nathan, Neera
    Keppler-Noreuil, Kim M.
    Biesecker, Leslie G.
    Moss, Joel
    Darling, Thomas N.
    DERMATOLOGIC CLINICS, 2017, 35 (01) : 51 - +
  • [5] PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
    Li, HaiXia
    Zeng, JianFang
    Shen, Keng
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 290 (06) : 1067 - 1078
  • [6] PI3K/mTOR Signaling Pathways in Medulloblastoma
    Mohan, Avinash L.
    Friedman, Marissa D.
    Ormond, D. Ryan
    Tobias, Michael
    Murali, Raj
    Jhanwar-Uniyal, Meena
    ANTICANCER RESEARCH, 2012, 32 (08) : 3141 - 3146
  • [7] Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia
    Park, Sophie
    Chapuis, Nicolas
    Tamburini, Jerome
    Bardet, Valerie
    Cornillet-Lefebvre, Pascale
    Willems, Lise
    Green, Alexa
    Mayeux, Patrick
    Lacombe, Catherine
    Bouscary, Didier
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (05): : 819 - 828
  • [8] PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
    HaiXia Li
    JianFang Zeng
    Keng Shen
    Archives of Gynecology and Obstetrics, 2014, 290 : 1067 - 1078
  • [9] Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer
    Morgos, Diana-Theodora
    Stefani, Constantin
    Miricescu, Daniela
    Greabu, Maria
    Stanciu, Silviu
    Nica, Silvia
    Stanescu-Spinu, Iulia-Ioana
    Balan, Daniela Gabriela
    Balcangiu-Stroescu, Andra-Elena
    Coculescu, Elena-Claudia
    Georgescu, Dragos-Eugen
    Nica, Remus Iulian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (03)
  • [10] PI3K/AKT/mTOR Inhibitors In Ovarian Cancer
    Mazzoletti, M.
    Broggini, M.
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (36) : 4433 - 4447